Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Furtado RHM, et al
GLP-1 medications reduce liver fat and inflammation, improving liver enzyme levels and helping reverse injury
A subset of liraglutide injection-treated patients (1,104 of 2,501, 44%) in five adult double-blind clinical trials of 26 weeks duration or longer were tested for the presence of anti-liraglutide antibodies at the end of treatment [see Clinical Studies (14.1)] and 102/1,104 (9%) of liraglutide injection-treated patients developed anti-liraglutide antibodies
Can these medications contribute to the development of eating disorders and disorderly eating? said Batash
Maintain social connections: Even if you do not feel like socialising, staying connected with loved ones is vital
and M.P.V., grants PID2020-114953RB-C21 funded by MICIU/AEI/10.13039/501100011033 to L.H